Get started
REMUS PHARMACEUTICALS LREMUS PHARMACEUTICALS LREMUS PHARMACEUTICALS L

REMUS PHARMACEUTICALS L

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

REMUS chart


Full chart

Key stats


Market capitalization
‪13.88 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
45.20
Basic EPS (TTM)
50.75 INR
Net income (FY)
‪215.37 M‬ INR
Revenue (FY)
‪2.12 B‬ INR
Shares float
‪1.87 M‬
Beta (1Y)
—

About REMUS PHARMACEUTICALS L


Sector
Health Technology
CEO
Arpit Deepakkumar Shah
Headquarters
Ahmedabad
Website
remuspharma.com
Founded
2015
ISIN
INE0O5T01011
FIGI
BBG01GNDCR97
Remus Pharmaceuticals Ltd. operates as a pharmaceutical company. It is engaged in the pharmaceutical business involving marketing, trading and distribution through third party of wide range of pharmaceutical formulations and products manufactured under loan license on contract manufacturing in India as well as in foreign countries. The company was founded by Arpit Deepakkumar Shah and Roma Vinodbhai Shah on September 21, 2015 and is headquartered in Ahmedabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

REMUS news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of REMUS is 2,340.10 INR — it has increased by 2.72% in the past 24 hours. Watch REMUS PHARMACEUTICALS L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange REMUS PHARMACEUTICALS L stocks are traded under the ticker REMUS.
REMUS stock has fallen by −3.23% compared to the previous week, the month change is a −10.74% fall, over the last year REMUS PHARMACEUTICALS L has showed a 74.15% increase.
REMUS reached its all-time high on Sep 3, 2024 with the price of 2,834.75 INR, and its all-time low was 427.80 INR and was reached on May 29, 2023. View more price dynamics on REMUS chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track REMUS PHARMACEUTICALS L financials in yearly and quarterly reports right on TradingView.
REMUS net income for the last half-year is ‪140.11 M‬ INR, while the previous report showed ‪158.89 M‬ INR of net income which accounts for −11.82% change. Track more REMUS PHARMACEUTICALS L financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REMUS PHARMACEUTICALS L EBITDA is ‪390.50 M‬ INR, and current EBITDA margin is 13.38%. See more stats in REMUS PHARMACEUTICALS L financial statements.
Like other stocks, REMUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REMUS PHARMACEUTICALS L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REMUS PHARMACEUTICALS L technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REMUS PHARMACEUTICALS L stock shows the neutral signal. See more of REMUS PHARMACEUTICALS L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.